
cizzlebio.com
May 24, 2025, 18:24
Cizzle Bio’s CIZ1B Lung Cancer Test Could Save Medicare $518 Million a Year While Improving Early Detection
Cizzle Bio shared a post on X:
“New ASCO2025 study: Cizzle Bio’s CIZ1B lung cancer test could save Medicare $518M/yr while improving early detection. 95% sensitivity for Stage I and 96% NPV = fewer procedures, earlier care. Study co-authored by Jennifer Hinkel.”
More posts featuring Cizzle Bio.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 24, 2025, 18:06
May 24, 2025, 17:58
May 24, 2025, 17:46
May 24, 2025, 17:18
May 24, 2025, 17:04
May 24, 2025, 16:38